Related Experiment Videos
Amniotic fluid embolism.
1Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, USA.
Obstetrics and Gynecology Clinics of North America
|September 3, 1999
Summary
Amniotic fluid embolism is a rare but deadly condition, causing significant maternal mortality. Its exact cause remains unclear, and current treatments are only supportive.
Area of Science:
- Obstetrics and Gynecology
- Critical Care Medicine
- Pathophysiology
Background:
- Amniotic fluid embolism (AFE) is a rare obstetric emergency.
- It is a leading cause of maternal mortality in the United States, with a high fatality rate (60%-80%).
- Survivors often experience severe long-term neurologic disability.
Purpose of the Study:
- To review the largest case series on amniotic fluid embolism to date.
- To better understand the pathophysiology of AFE.
- To evaluate the clinical manifestations and compare them to other shock syndromes.
Main Methods:
- Review of the largest available case series on amniotic fluid embolism.
- Analysis of the physiologic and hematologic manifestations of AFE patients.
- Comparison of AFE's clinical presentation with septic shock and anaphylactic shock.
Main Results:
- The pathophysiology of amniotic fluid embolism is not well understood.
- Physiologic and hematologic findings in AFE resemble septic and anaphylactic shock more than embolic events.
- Patient care for AFE is primarily supportive.
Conclusions:
- Amniotic fluid embolism presents with unique clinical features distinct from typical embolic phenomena.
- Further research is needed to elucidate the pathophysiology of AFE.
- Currently, no specific therapies improve survival rates for amniotic fluid embolism.